Morphological and functional abnormalities in neuromuscular junctions of drosoph1la melanogaster induced by the expression of human app gene

Tsitologiya

Volumn 54, Issue 5, 2012, Pages 421-429

  Sarantseva, S V ^a   Kislik, G A ^a   Tkacheno, N A ^a   Vasiliev, A N ^c   Schwarzman, A L ^a,b  

^a PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

Alzheimer disease; APP; Drosophila melanogaster; Neuromuscular junctions

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN; FLUORESCENT DYE; FM 4 64; FM 4-64; PYRIDINIUM DERIVATIVE; QUATERNARY AMMONIUM DERIVATIVE; SECRETASE;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; BIOLOGICAL MODEL; DROSOPHILA MELANOGASTER; EXOCYTOSIS; GENE EXPRESSION; GENETICS; HUMAN; LARVA; METABOLISM; MITOCHONDRION; MOTONEURON; MUTATION; NEUROMUSCULAR SYNAPSE; PATHOPHYSIOLOGY; SECRETION; SYNAPTOSOME; TRANSGENIC ANIMAL; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DROSOPHILA MELANOGASTER; EXOCYTOSIS; FLUORESCENT DYES; GENE EXPRESSION; HUMANS; LARVA; MITOCHONDRIA; MODELS, BIOLOGICAL; MOTOR NEURONS; MUTATION; NEUROMUSCULAR JUNCTION; PRESYNAPTIC TERMINALS; PYRIDINIUM COMPOUNDS; QUATERNARY AMMONIUM COMPOUNDS;

EID: 84864547092     PISSN: 00413771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Anandatheerthavarada H. K., Devi L. 2007. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease. Neuroscientist. 13 :626-638.
2. Annaert W., De Strooper B. 2002. A cell biological perspective on Alzheimer's disease. Annu. Rev. Cell Develop. Biol. 18 : 25-51.
3. Bonini N. M., Fortini M. E. 2003. Human neurodegenerative disease modeling using Drosophila. Annu. Rev. Neurosci. 26 : 627-56.
4. Budnik V, Ruiz-Canada C. 2006. The fly neuromuscular junction: structure and function. Second edition. Int. Rev. Neurobiol. V. 75. San Diego: Acad. Press. 425 p.
5. Gunawardena S., Goldstein L. S. 2001. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron. 32 : 389-401.
6. Hardy J., Selkoe D. J. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. An updated summary of the amyloid hypothesis Science. 297 : 353-356.
7. Hollenbeck P. J. 2005. Mitochondria and neurotransmission: evacuating the synapse. Neuron. 47 : 331-333.
8. Jin L. W., Ninomiya H, Roch J. M., Schubert D., Masliah E., Otero D. A., Saitoh T. 1994. Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14 : 5461-5470.
9. Kuromi H, Kidokoro Y. 1998. Two distinct pools of synaptic vesicles in single presynaptic boutons in a temperature-sensitive Drosophila mutant, shibre. Neuron. 20 : 917-925.
10. Leyssen M., Ayaz D., Hebert S. S., Reeve S., De Strooper B., Hassan B. A. 2005. Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain. EMBO J. 24:2944-2955.
11. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., Terry R. 1994. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci. Lett. 174 : 67-72.
12. Moechars D., Dewachter I., Lorent K., Reverse D., Baeke-landt V., Naidu A., Tesseur I., Spittaels K., Haute C. V., Checler F., Godaux E., Cordell B., Van Leuven F. 1999. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274 : 6483- 6492.
13. Mucke L., Masliah E., Yu G. Q., Mallory M., Rockenstein E. M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. 2000. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: sy-naptotoxicity without plaque formation. J. Neurosci. 20 : 4050- 4058.
14. Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., KayedR., MetherateR., Mattson M. P., Akbari Y., Laferla F. M. 2003. Triple-transgcnic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 39:409-421.
15. Rovelet-Lecrux A., Hannequin D., Raux G., Le Meur N., Laquerriere A., Vital A., Dumanchin C., Feuillette S., Brice A., Vercelletto M., Dubas F., Frebourg T, Campion D. 2006. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat. Genet. 38 : 24-26.
16. Rusu P., Jansen A., Soba P., Kirsch J., Lower A., Merdes G., Kuan Y. H, Jung A., Beyreuther K., Kjaerulff O., Kins S. 2007. Axonal accumulation of synaptic markers in APP transgenic Drosophila depends on the NPTY motif and is paralleled by defects in synaptic plasticity. Eur. J. Neurosci. 25 : 1079-1086.
17. Sarantseva S., Timoshenko S., Bolshakova O., Karaseva E., Rodin D., Schwarzman A. L.,Vitek M. P. 2009. Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease. PIos One. 4:e8191.
18. Seabrook G. R., Smith D. W., Bowery B. J., Easter A., Reynolds T, Fitzjohn S. M., Morton R. A., Zheng H., Dawso G. R., Siri-nathsinghji D. J. 1999. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology. 38 : 349-359.
19. Seeger G., Gartner E., Ueberham U., Rohn S., Arendt T. 2009. FAD-mutation of APP is associated with a loss of its synaptotrop-hic activity. Neurobiol. Dis. 35 : 258-263.
20. Selkoe D. J. 2001. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzhe-imers Dis. 3 : 75-80.
21. Senechal Y., Larmet Y., Dev K K. 2006. Unraveling in vivo functions of amyloid precursor protein: insights from knockout and knockdown studies. Neurodegenerative Dis. 3 : 134-147.
22. Stokin G. B., Lillo C, Falzone T, Brusch R. G., Rockenstein E., Mount S. L., Raman R., Davies P., r Masliah T, Williams D. S., Goldstein L. S. 2005. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science. 307 : 1282-1288.
23. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill A., Hansen L. A., Katzman R. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 : 572- 580.
24. Ting J. T, Kelley B. G., Lambert T. J. Cook D. G., Sullivan J. M. 2007. Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms. Proc. Nat. Acad. Sci. USA. 104 : 353- 358.
25. Torroja L., Chu H, Kotovsky I., White K. 1999a. Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr. Biol. 9 :489-492.
26. Torroja L., Packard M., Gorczyca M., White K, Budnik V. 1999b. The Drosophila P-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J. Neurosci. 15 : 7793-7803.
27. Verstreken P., Ohyama T, Bellen H. J. 2008. FM 1-43 labeling of synaptic vesicle pools at the Drosophila neuromuscular junction. Methods Mol. Biol. 440 : 349-369.
28. Walsh D. M., Selkoe D. J. 2004. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron. 44 : 181- 193.
29. Yagi Y, Tomita S., Nakamura M., Suzuki T. 2000. Overexpression of human amyloid precursor protein in Drosophila. Mol. Cell. Biol. Res. Commun. 4 : 43-49.
30. Zenisek D., Matthews G. 2000. The role of mitochondria in presynaptic calcium handling at a ribbon synapse. Neuron. 25 : 229-237.
31. Zhang Y. Q., Rodesch C. K., Broadie K. 2002. Living synaptic vesicle marker: synaptotagmin - GFP. Genesis. 34 : 142-145.